Top Markets
#1 Official Trump Official Trump +32.45%
#2 EXOD EXOD +22.08%
#3 Movement Movement +21.25%
#4 Mubarak Mubarak +19.14%
#5 POL (ex-MATIC) POL (ex-MATIC) +18.85%
#6 Wrapped POL Wrapped POL +18.83%
#7 Pearl Pearl +17.90%
#8 Wrapped STX (Velar) Wrapped STX (Velar) +17.22%
#9 Melania Meme Melania Meme +16.21%
#10 Glidr Glidr +11.25%
Coin of the day
Official Trump Official Trump
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
MaaT Pharma S.A. MaaT Pharma S.A.

MaaT Pharma S.A.

MAAT
Kedudukan dalam Saham #23616
MaaT Pharma SA operates as a clinical-stage biotechnology company, focused on... MaaT Pharma SA operates as a clinical-stage biotechnology company, focused on the discovery and advancement of microbiome-based biotherapies, primarily for the treatment of solid cancer tumors. Its development pipeline features MaaT013, which has successfully completed Phase 2 clinical trials for acute graft-versus-host disease (aGVHD) and is also undergoing preclinical evaluation for melanoma. Another therapeutic candidate, MaaT033, is currently in Phase 1b clinical trials, aiming to improve survival outcomes for patients with acute myeloid leukemia (AML) or other liquid malignancies following allogeneic hematopoietic stem cell transplantation. Furthermore, MaaT03X is being developed specifically for solid tumor applications. The company was founded in 2014 and maintains its headquarters in Lyon, France.
Harga Saham
$3.78
Disegerakkan terakhir: 2026-08-21
Modal Pasaran
$71.20M
Perubahan (1 hari)
2.24%
Perubahan (1 tahun)
-43.37%
Negara
FR
Perdagangan MaaT Pharma S.A. (MAAT)

Kategori

Healthcare
Sejarah hasil dividen untuk MaaT Pharma S.A. (MAAT)
Hasil dividen (TTM) bagi MaaT Pharma S.A. (simbol saham: MAAT) pada 2026 adalah: 0
Purata hasil dividen 5 tahun terakhir: 0.00%
Sejarah hasil dividen untuk MaaT Pharma S.A. (MAAT) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil dividen (TTM) untuk syarikat serupa atau pesaing
Syarikat Hasil Dividen Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH